Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Trial Evaluating Intravenous AZD9150 (Antisense STAT3) With MEDI4736 (Anti-PD-L1) in Patients With Advanced Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer

NCT02983578 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT02983578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02983578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Trial Evaluating Intravenous AZD9150 (Antisense STAT3) With MEDI4736 (Anti-PD-L1) in Patients With Advanced Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 2, 2017
Completion date
August 30, 2025
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced colorectal carcinoma, advanced lung non-small cell carcinoma, lung non-small cell carcinoma, mismatch repair deficiency, refractory colorectal carcinoma, refractory lung carcinoma, refractory pancreatic carcinoma, stage ii pancreatic cancer ajcc v8, stage iii colorectal cancer ajcc v8, stage iii lung cancer ajcc v8, stage iii pancreatic cancer ajcc v8, stage iiia colorectal cancer ajcc v8, stage iiia lung cancer ajcc v8, stage iiib colorectal cancer ajcc v8, stage iiib lung cancer ajcc v8, stage iiic colorectal cancer ajcc v8, stage iiic lung cancer ajcc v8, stage iv colorectal cancer ajcc v8, stage iv lung cancer ajcc v8, stage iv pancreatic cancer ajcc v8, stage iva colorectal cancer ajcc v8, stage iva lung cancer ajcc v8, stage ivb colorectal cancer ajcc v8, stage ivb lung cancer ajcc v8, stage ivc colorectal cancer ajcc v8